New knee osteoarthritis drug shows promise in Mid-Stage trial
NCT ID NCT06485843
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 32 times
Summary
This study tests a new treatment called OA-SYS for people with moderate to severe knee osteoarthritis. The main goal is to see if it is safe and well-tolerated by 400 adults aged 35 to 75. Researchers will also check if it reduces pain and the need for pain relievers. This is an early step to find a better way to manage this common joint condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Orthopedic & Sports Medicine Institute of Las Vegas
RECRUITINGLas Vegas, Nevada, 89117, United States
Contact
Conditions
Explore the condition pages connected to this study.